6 Einträge gefunden

1. Worst itch numerical rating scale for prurigo nodularis: a psychometric evaluation

   1. Ständer, S
   2. Zeidler, C
   3. Pereira, M
   4. Szepietowski, J C
   5. McLeod, L
   6. Qin, S
   7. Williams, N

   2022 - Forschungsinformationssystem des UKE
2. Secukinumab treatment leads to normalization of quality of life and disease symptoms in psoriasis patients with or without prior systemic psoriasis therapy: the PROSE study results

   1. Augustin, M
   2. Dauden, E
   3. Mrowietz, U
   4. Konstantinou, M P
   5. Gerdes, S
   6. Kingo, K
   7. Szepietowski, J C

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
3. Time to relapse after tildrakizumab withdrawal in patients with moderate-to-severe psoriasis who were responders at week 28: post hoc analysis through 64 weeks from reSURFACE 1 trial

   1. Warren, R B
   2. Carrascosa, J M
   3. Fumero, E
   4. Schoenenberger, A
   5. Lebwohl, M G
   6. Szepietowski, J C
   7. Reich, K

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
4. Secukinumab dosing optimization in patients with moderate-to-severe plaque psoriasis: results from the randomized, open-label OPTIMISE study

   1. Reich, K
   2. Puig, L
   3. Szepietowski, J C
   4. Paul, C
   5. Lacour, J P
   6. Tsianakas, A
   7. Sieder, C

   2020 - Forschungsinformationssystem des UKE
5. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes on quality of life issues in dermatologic patients during the COVID-19 pandemic

   1. Chernyshov, P V
   2. Tomas-Aragones, L
   3. Augustin, M
   4. Svensson, A
   5. Bewley, A
   6. Poot, F
   7. Szepietowski, J C

   2020 - Forschungsinformationssystem des UKE
6. Quimp (quality of life impairment): an addition to the quality of life lexicon

   1. Chernyshov, P V
   2. Linder, M D
   3. Pustišek, N
   4. Manolache, L
   5. Szepietowski, J C
   6. Tomas-Aragones, L
   7. Marron, S E

   2018 - Forschungsinformationssystem des UKE